Abstract
To evaluate the value of clinical trials on intratympanic steroid therapy in Ménière’s disease (MD), idiopathic sudden sensorineural hearing loss (ISSNHL) and rapidly progressive sensorineural hearing loss (RPSNHL). Medline and Pubmed databases from 1966 to present were searched for clinical studies on intra- or transtympanic (cortico)steroid therapy of MD, ISSNHL and RPSNHL. Results were cross-checked with additional databases to obtain a complete data set. Clinical trials were evaluated on the basis of comparability, internal and external validity. Articles were judged using the following questions: was a randomised double-blind controlled trial performed? Which criteria were used to confirm the diagnosis of MD, ISSNHL, RPSNHL? Which therapy was evaluated? How long was the follow-up? Which criteria were used to evaluate the results? Reliable evidence on the efficiency, optimum dosage and administration schedule of intratympanic steroid therapy in MD, ISSNHL and RPSNHL is lacking, therefore further investigation is required.
Similar content being viewed by others
References
Ryan AF, Harris JP, Keithley EM (2002) Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol (Stockh) 548(Suppl):38–43
Derebery MJ (1996) Allergic and immunologic aspects of Ménière’s disease. Otolaryngol Head Neck Surg 114(3):360–365
Yoo TJ, Kwon SS (2002) Molecular mechanism of autoimmune hearing loss. Acta Otolaryngol (Stockh) 548(Suppl):3–9
Fuse T, Hayashi T, Oota N et al (2003) Immunological responses in acute low-tone sensorineural hearing loss and Ménière’s disease. Acta Otolaryngol (Stockh) 123:26–31
McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589
Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in sudden sensorineural hearing loss. Laryngoscope 94:664–666
Silverstein H, Choo D, Rosenberg S, Kuhn J, Seidman MD, Stein I (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75(8):468–471
Shirwany NA, Seidman MD, Tang W (1998) Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 19(2):230–235
Fukushima M, Kitahara T, Uno Y, Fuse Y, Doi K, Kubo T (2002) Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol (Stockh) 122:600–606
Chandrasekhar S, Rubinstein R, Kwartler J et al (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122(4):521–528
Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid Pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109(Suppl 91):1–17
Jackson LE, Silverstein H (2002) Chemical perfusion of the inner ear. Otolaryngol Clin North Am 35:639–653
Committee on Hearing and Equilibrium AAO-HNS (1995) Committee on hearing and equilibrium guidelines for the diagnosis and the evaluation of therapy in Ménière’s disease. Otolaryngol Head Neck Surg 113(3):181–185
Stokroos RJ, Albers F (1996) The etiology of idiopathic sudden sensorineural hearing loss. A review of the literature. Acta Oto-rhino-laryngol Belg 50:69–76
Moscicki R, San Martin J, Quintera C (1994) Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and reponse to corticosteroid treatment. JAMA 272(8):611–616
Silverstein H, Isaacson J, Olds M, Rowan P, Rosenberg S (1998) Dexamethasone inner ear perfusion for the treatment of Ménière’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 19(2):196–201
Sennaroglu L, Sennaroglu G, Gursel B, Dini FM (2001) Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Ménière’s disease. Otolaryngol Head Neck Surg 125(5):537–43
Itoh A, Sakata E (1991) Treatment of vestibular disorders. Acta Otolaryngol (Stockh) Suppl 481:617–623
sShea JJ (1997) The role of dexamethasone or streptomycin perfusion in the treatment of Meniere’s disease. Otolaryngol Clin North Am 30(6):1051–1059
Hirvonen T, Peltomaa M, Ylikoski J (2000) Intratympanic and systemic dexamethasone for Ménière’s disease. ORL J Otorhinolaryngol Relat Spec 62(3):117–120
Barrs D, Keyser J, Stallworth C, McElveen JJ (2001) Intratympanic steroid injections for intractable Ménière’s disease. Laryngoscope 111(12):2100–2104
Chandrasekhar S (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22(1):18–23
Shea JJJ, Xianxi G (1996) Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for meniere’s disease. Otolaryngol Clin North Am 29(2):353–358
Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125(3):142–146
Sennaroglu L, Dini FM, Sennaroglu G, Gursel B, Ozkan S (1999) Transtympanic dexamethasone application in Ménière’s disease: an alternative treatment for intractable vertigo. J Larngol Otol 113:217–21
Arriaga M, Goldman S (1998) Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 108(11 Pt 1):1682–1685
Alzamil KS, Linthicum FHJ (2000) Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 109(1):30–32
Plontke S, Zenner HP (2002) Pharmacokinetic considerations in intratympanic drug delivery to the inner ear. Acta Oto-rhino-laryngol Belg 56:369–370
Shea JJ Jr, Ge X (1996) Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière’s disease. Otolaryngol Clin North Am 29(2):353–358
Shea JJ Jr (1993) Classification of Ménière’s disease. Am J Otol 14:224–229
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alles, M.J.R.C., der Gaag, M.A. & Stokroos, R.J. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 263, 791–797 (2006). https://doi.org/10.1007/s00405-006-0065-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-006-0065-3